Cargando…
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting
Differentiation has been proposed as a therapeutic strategy for glioblastoma (GBM) in part due to observations of stem-like cells in GBM that have been shown to undergo terminal differentiation in response to growth factor withdrawal and BMP activation. However, the effects of long term exposure to...
Autores principales: | Balasubramaniyan, Veerakumar, Vaillant, Brian, Wang, Shuzhen, Gumin, Joy, Butalid, M. Elena, Sai, Ke, Mukheef, Farah, Kim, Se Hoon, Boddeke, H.W.G.M., Lang, Frederick, Aldape, Kenneth, Sulman, Erik P., Bhat, Krishna P., Colman, Howard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741584/ https://www.ncbi.nlm.nih.gov/pubmed/26307681 |
Ejemplares similares
-
OTME-23. Single-cell transcriptomic and epigenomic immune landscape of isocitrate dehydrogenase stratified human gliomas
por: Gupta, Pravesh, et al.
Publicado: (2021) -
PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells
por: Modrek, Aram S., et al.
Publicado: (2022) -
Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
por: Khan, Sabbir, et al.
Publicado: (2020) -
The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells
por: Dong, Jianwen, et al.
Publicado: (2018) -
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells
por: Khan, Sabbir, et al.
Publicado: (2021)